Targeting of influenza epitopes to murine CR1/CR2 using single-chain antibodies

József Prechl, Andrey Tchorbanov, Attila Horváth, Dana C. Baiu, Wouter Hazenbos, Éva Rajnavölgyi, István Kurucz, Peter J.A. Capel, Anna Erdei

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Single-chain variable fragment (scFv) antibodies are genetically engineered molecules comprising the variable regions responsible for specific binding. scFv that recognize certain surface molecules on professional antigen presenting cells could therefore be suitable for targeting Ag to these cells. We have produced an scFv that recognizes murine complement receptors 1 and 2 (CR1/CR2) and genetically fused it with different numbers of influenza hemagglutinin peptides which contain both B and T cell epitopes. The CR1/CR2 specific hybridoma 7G6 was used for RT-PCR to obtain the variable regions, which were then combined to create an scFv fragment. The influenza hemagglutinin intersubunit peptide HA317-41 (IP) was engineered to the N terminus of the scFv in one, two or three copies. The so obtained IP1-37G6scFv still bound the complement receptors; the peptides in the construct were recognized by the peptide specific monoclonal IP2-11-1 on Western blots and ELISAs. The CR1/CR2 positive B lymphomas A20 and 2PK3 presented the peptide to an I-E(d) restricted IP specific T cell hybridoma more efficiently when incubated with the IP17G6 constructs as compared to the free peptide. The results suggest that scFv could work as targeting devices in subunit vaccines.

Original languageEnglish
Pages (from-to)159-165
Number of pages7
JournalImmunopharmacology
Volume42
Issue number1-3
DOIs
Publication statusPublished - May 1999

    Fingerprint

Keywords

  • Antigen targeting
  • Murine complement receptors type 1 and 2 (CR1-CR2)
  • Single-chain variable fragment antibodies (scFv)

ASJC Scopus subject areas

  • Pharmacology

Cite this